When stratified by rs11136000 and APOE genotypes, we found a significant effect of the risk allele C on CSF Tau levels in AD patients carrying apoE4, with homozygous CC individuals showing significantly higher CSF Tau than heterozygous CT carriers (Fig. 1c). The gene discussed is MAPT; the disease is Alzheimer disease.